Lantern Pharma Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for LTRN, updated each market day.
LTRN AI Sentiment
AI predicts Lantern Pharma Inc. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Lantern Pharma Inc. Common Stock
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.
Sector
Exchange
Market Cap
$21,046,283
Cap Tier
Employees
16
Headquarters
DALLAS, TX
Listed Since
June 11, 2020
Website
LTRN Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
LTRN Volatility
Lantern Pharma Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
